Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2008, Vol. 111, No. 7, pp. 3571-3578.
Prepublished online as a Blood First Edition Paper on January 15, 2008; DOI 10.1182/blood-2007-07-100057.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-07-100057v1
111/7/3571    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coudert, J. D
Right arrow Articles by Held, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coudert, J. D
Right arrow Articles by Held, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 6, 2007
Accepted January 6, 2008

Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways

Jerome D Coudert, Leonardo Scarpellino, Frederic Gros, Eric Vivier, and Werner Held*

Ludwig Institute for Cancer Research, Lausanne Branch and University of Lausanne, Epalinges, Switzerland
Centre d'Immunologie de Marseille-Luminy, Universite de la Meditarranee, Campus de Luminy, Marseille, France

* Corresponding author; email: wheld{at}isrec.unil.ch.

NKG2D is a multi-subunit activation receptor, which allows NK cells to detect and eliminate stressed, infected and transformed host cells. However, the chronic exposure of NK cells to cell-bound NKG2D ligands has been shown to impair NKG2D function both in vitro and in vivo. Here we have tested whether continuous NKG2D engagement selectively impacted NKG2D function or whether heterologous NK cell activation pathways were also affected. We find that sustained NKG2D engagement induces cross-tolerization of several unrelated NK cell activation receptors. We show that receptors that activate NK cells via the DAP12/KARAP and DAP10 signaling adaptors, such as murine NKG2D and Ly49D, cross-tolerize preferentially NK cell activation pathways that function independent of DAP10/12, such as antibody-dependent cell mediated cytotoxicity and missing self-recognition. Conversely, DAP10/12-independent pathways are unable to cross-tolerize unrelated NK cell activation receptors such as NKG2D or Ly49D. These data define a class of NK cell activation receptors that can tolerize mature NK cells. The reversible suppression of the NK cells' cytolytic function likely reduces the NK cells' efficacy to control endogenous and exogenous stress yet may be needed to limit tissue damage.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020